RNA-based therapies targeting APOC3 lower triglyceride levels in patients with hypertriglyceridaemia

Nat Rev Cardiol. 2024 Jun;21(6):353. doi: 10.1038/s41569-024-01034-w.
No abstract available

Publication types

  • Comment

MeSH terms

  • Apolipoprotein C-III* / blood
  • Humans
  • Hypertriglyceridemia* / blood
  • Hypertriglyceridemia* / drug therapy
  • Hypertriglyceridemia* / therapy
  • Triglycerides* / blood

Substances

  • APOC3 protein, human